J2183 HCPCS code: Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
J2183 is the HCPCS Level II code for injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 60 per day on DME suppliers.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-07-01 |
| Last action effective | 2025-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 60 | Prescribing Information |
| outpatient hospital claims | 60 | Prescribing Information |
| practitioner claims | 60 | Prescribing Information |
What changed for J2183
- 2024-07-01: J2183 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2183?
J2183 is the HCPCS Level II code for injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg. Short descriptor: "Inj meropenem (wg crit care)".
Does Medicare cover J2183?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2183 can be billed per day?
60 on DME suppliers; 60 on outpatient hospital claims; 60 on practitioner claims (NCCI medically unlikely edits).
Related J21 codes
- J2150 — Injection, mannitol, 25% in 50 ml
- J2151 — Injection, mannitol, 250 mg
- J2170 — Injection, mecasermin, 1 mg
- J2175 — Injection, meperidine hydrochloride, per 100 mg
- J2180 — Injection, meperidine and promethazine hcl, up to 50 mg
- J2182 — Injection, mepolizumab, 1 mg
- J2184 — Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185 — Injection, meropenem, 100 mg
- J2186 — Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2183
- Watch J2183 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2183
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.